- Home
- SNGX vs JCSE Comparison
SNGX vs JCSE Comparison
Compare SNGX & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- JCSE
- Stock Information
- Founded
- SNGX 1987
- JCSE 1999
- Country
- SNGX United States
- JCSE Singapore
- Employees
- SNGX N/A
- JCSE N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- JCSE Miscellaneous manufacturing industries
- Sector
- SNGX Health Care
- JCSE Consumer Discretionary
- Exchange
- SNGX Nasdaq
- JCSE Nasdaq
- Market Cap
- SNGX 7.4M
- JCSE 7.6M
- IPO Year
- SNGX 1987
- JCSE 2022
- Fundamental
- Price
- SNGX $2.43
- JCSE $1.55
- Analyst Decision
- SNGX
- JCSE
- Analyst Count
- SNGX 0
- JCSE 0
- Target Price
- SNGX N/A
- JCSE N/A
- AVG Volume (30 Days)
- SNGX 31.1K
- JCSE 14.9K
- Earning Date
- SNGX 03-14-2025
- JCSE 10-30-2024
- Dividend Yield
- SNGX N/A
- JCSE 5.81%
- EPS Growth
- SNGX N/A
- JCSE N/A
- EPS
- SNGX N/A
- JCSE 0.12
- Revenue
- SNGX $364,183.00
- JCSE $14,723,999.00
- Revenue This Year
- SNGX N/A
- JCSE N/A
- Revenue Next Year
- SNGX $76.64
- JCSE N/A
- P/E Ratio
- SNGX N/A
- JCSE $12.55
- Revenue Growth
- SNGX N/A
- JCSE N/A
- 52 Week Low
- SNGX $1.83
- JCSE $0.64
- 52 Week High
- SNGX $14.88
- JCSE $2.39
- Technical
- Relative Strength Index (RSI)
- SNGX 46.06
- JCSE 53.49
- Support Level
- SNGX $2.35
- JCSE $1.42
- Resistance Level
- SNGX $2.47
- JCSE $1.71
- Average True Range (ATR)
- SNGX 0.13
- JCSE 0.08
- MACD
- SNGX 0.04
- JCSE -0.02
- Stochastic Oscillator
- SNGX 61.36
- JCSE 44.83
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About JCSE JE Cleantech Holdings Limited
JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.